Home > Healthcare > Medical Devices > Therapeutic Devices > Bovine-based Collagen for Biomedical Application Market

Bovine-based Collagen for Biomedical Application Market Trends

Report ID: GMI9698
Published Date: May 2024
Report Format: PDF

Download Free Sample

Bovine-based Collagen for Biomedical Application Market Trends

Developments in 3D bioprinting and bioink has greatly benefited bovine-based collagen product manufacturers in creating complex tissue structures and organs. 3D bioprinting technology holds promising potential for developing personalized treatment options and enabling advanced tissue repair. Growing adoption of direct link writing printing methods is gaining popularity for developing bovine collagen-based engineered tissues. According to an August 2023 study published by Multidisciplinary Digital Publishing Institute, 3D-printed scaffolds are promoting the cellular attachment and proliferation, making them a promising material for personalized, patient-specific tissue regeneration applications. As a result, the demand for 3D printing bovine-collagen products is increasing globally.
Moreover, the vendors are increasingly focusing towards meeting the growing demand for high concentration collagen, that are finding extensive use in wound healing, cosmetic, and orthopedic procedures. Higher concentrations of collagen have ensured better bioavailability and integration with human tissues, enhancing the efficacies of medical treatments.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Bovine-based collagen for biomedical application industry size was worth USD 1 billion in 2023 and is projected to expand at 9.8% CAGR from 2024 to 2032, due to the growing preference for bovine collagen-based hemostats in surgical procedures.

The wound dressing segment in the bovine-based collagen for biomedical application industry recorded 28.4% market share in 2023 and is projected to expand at significant rate between 2024 and 2032, due to the increasing adoption of hydrolyzed bovine-collagen products in wound care dressings.

The hospital pharmacies distribution channel segment in the bovine-based collagen for biomedical application industry accounted for USD 641.4 million in revenue in 2023 and is projected grow at significant rate from 2024 to 2032, owing to the direct access provided by these channels for patients who are admitted for treatment or are undergoing surgical interventions.

North America bovine-based collagen for biomedical application industry accounted for 42.1% market share in 2023 and is estimated to depict substantial gains by 2032, led by the presence of many leading manufacturers and suppliers of bovine collagen products in the region.